# Effects of Omega-3 Polyunsaturated Fatty Acids, Docosahexaenoic Acid and Eicosapentaenoic Acid, on Post-Surgical Complications in Surgical Trauma Patients: Mechanisms, Nutrition, and Challenges

**Authors:** Asma Ouagueni, Raed M. Al-Zoubi, Ahmad Zarour, Abdulla Al-Ansari, Hiba Bawadi

PMC · DOI: 10.3390/md22050207 · Marine Drugs · 2024-04-30

## TL;DR

This paper reviews how omega-3 fatty acids may reduce post-surgical complications in trauma patients by reducing inflammation and improving recovery outcomes.

## Contribution

The paper provides a comprehensive review of omega-3 PUFA effects on post-surgical complications, highlighting variability and administration routes.

## Key findings

- Omega-3 PUFAs show anti-inflammatory and antioxidant effects that may improve post-surgical outcomes.
- Positive effects are observed in liver surgery and acute respiratory distress syndrome patients.
- Inconsistent results in cardiac surgeries suggest administration route influences outcomes.

## Abstract

This paper aims to provide an in-depth review of the specific outcomes associated with omega-3 polyunsaturated fatty acids (PUFAs), focusing on their purported effects on post-surgical complications in trauma patients. A comprehensive investigation of omega-3 polyunsaturated fatty acids was conducted until February 2023 using the PubMed database. Surgical trauma is characterized by a disruption in immune response post surgery, known to induce systemic inflammation. Omega-3 PUFAs are believed to offer potential improvements in multiple post-surgical complications because of their anti-inflammatory and antioxidant properties. Inconsistent findings have emerged in the context of cardiac surgeries, with the route of administration playing a mediating role in these outcomes. The effects of omega-3 PUFAs on post-operative atrial fibrillation have exhibited variability across various studies. Omega-3 PUFAs have demonstrated positive effects in liver surgery outcomes and in patients with acute respiratory distress syndrome. Omega-3 is suggested to offer potential benefits, particularly in the perioperative care of patients undergoing traumatic procedures. Incorporating omega-3 in such cases is hypothesized to contribute to a reduction in certain surgical outcomes, such as hospitalization duration and length of stay in the intensive care unit. Therefore, comprehensive assessments of adverse effects can aid in identifying the presence of subtle or inconspicuous side effects associated with omega-3.

## Linked entities

- **Chemicals:** Docosahexaenoic Acid (PubChem CID 445580), Eicosapentaenoic Acid (PubChem CID 5282847)
- **Diseases:** acute respiratory distress syndrome (MONDO:0006502), atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249), acute respiratory distress syndrome (MESH:D012128), Complications (MESH:D008107), Trauma (MESH:D014947), atrial fibrillation (MESH:D001281)
- **Chemicals:** Eicosapentaenoic Acid (MESH:D015118), Docosahexaenoic Acid (MESH:D004281), PUFAs (MESH:D005231), Omega-3 PUFAs (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11123418/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11123418/full.md

## References

93 references — full list in the complete paper: https://tomesphere.com/paper/PMC11123418/full.md

---
Source: https://tomesphere.com/paper/PMC11123418